CTN-0106: Derivation and Validation of New Measurement-Based Care Tools Derived from the Brief Addiction Monitor

Andrew Saxon, MD
Co-Lead Investigator

Department of Psychiatry and Behavioral Sciences University of Washington

James McKay, PhD
Co-Lead Investigator

Philadelphia Veterans Affairs Medical Center
Center of Excellence in Substance Abuse Treatment and Education

Given the severity of the current opioid crisis, there is a pressing need to maximize the effectiveness of our interventions and increase retention in medication for opioid use disorder (MOUD) treatment. Measurement-based care (MBC), in which patient progress is regularly and systematically assessed to aid in treatment decisions, is a promising approach. Assessment tools are needed that can be administered quickly and that yield information that can be used to suggest improvements in treatment. In this study, the Investigator will conduct a series of analyses with data from the Brief Addiction Monitor (BAM), which has been selected for a national MBC initiative within the Veteran’s Administration. The goal of the work will be to derive and validate two new scales from the BAM. One scale is intended for use in opioid use disorder (OUD) specialty care programs. The second version is intended for use in primary care based MOUD.

Funded by the NIH HEAL InitiativeSM.

    Node Involvement

    Lead Node(s):

  • Pacific Northwest Node

  • All Participating Nodes:

  • Pacific Northwest Node